FIELD: medicine.
SUBSTANCE: method involves subcutaneously introducing Recormon at a dose of 10000 U one day before beginning chemotherapy treatment. Next to it, Recormon is introduced at the same dose every week during 6 weeks. Patient having bone metastases additionally intravenously receive 4 mg of Zometa injected during 30 min or 2 mg of Bondronat during 120 min.
EFFECT: increased and stabilized blood hemoglobin concentration.
2 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF PLURAL OSTEAL METASTASISES DURING MAMMARY GLAND CANCER | 2007 |
|
RU2332992C1 |
METHOD FOR TREATING MALIGNANT NEOPLASMS OF EPITHELIUM ORIGIN | 1994 |
|
RU2106866C1 |
METHOD FOR INCREASING THE LEVEL OF HEMOGLOBIN IN THE BLOOD IN A PATIENT WITH CANCER | 2019 |
|
RU2773153C1 |
METHOD FOR TREATING PATIENTS POSSESSING DIFFUSE FORMS OF MAMMARY GLAND CARCINOMA | 1996 |
|
RU2133607C1 |
METHOD OF PREOPERATIVE CORRECTION OF ANEMIA IN PATIENTS WITH COLORECTAL CANCER WITH LIVER METASTASES | 2023 |
|
RU2811959C1 |
METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH METASTATIC CEREBRAL LESION | 2005 |
|
RU2290974C1 |
THERAPEUTIC WAYS FOR TREATING PATIENTS WITH RECOMBINANT ERYTHROPOIETIN OF HIGH ACTIVITY AND DECREASED SIDE EFFECTS | 2001 |
|
RU2282460C2 |
COMBINATION CELL IMMUNOTHERAPY OF MALIGNANT TUMORS | 2020 |
|
RU2787623C2 |
METHOD OF TREATING ANEMIA IN CHEMORADIATION THERAPIES | 2009 |
|
RU2393880C1 |
METHOD OF TREATING SPINE TUMOURS | 2014 |
|
RU2551622C1 |
Authors
Dates
2008-01-10—Published
2005-11-30—Filed